在心血管衰老和疾病中表观遗传修饰和新兴的治疗点
Yurou Qiu1, Qing Xu2, Peichen Xie2
1GMU-GIBH Joint School of Life Sciences, Department of Cardiology, Guangzhou Institute of Cardiovascular Disease, Guangdong Key Laboratory of Vascular Diseases, the Second Affiliated Hospital, The Guangdong-Hong Kong-Macao Joint Laboratory for Cell Fate Regulation and Diseases, State Key Laboratory of Respiratory Disease, The Sixth School of Clinical Medicine, the Affiliated Qingyuan Hospital (Qingyuan People's Hospital), Guangzhou Medical University, Guangdong Pharmaceutical University, Guangzhou, Guangdong, PR China.
表观遗传学,即研究基因表达的变化而不改变DNA序列,为心血管疾病提供了新的见解. 本综述探讨了心血管衰老和疾病的表观遗传机制和治疗点.
科学领域:
- 心血管生物学 心血管生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子医学是分子医学.
背景情况:
- 心血管疾病的机制是复杂的,并未完全理解.
- 表观遗传学影响基因表达和遗传性特征,影响心血管健康.
- 老龄化通过表观遗传变化加剧心血管疾病的风险.
研究的目的:
- 审查心血管衰老和疾病中的表观遗传调节.
- 详细介绍涉及的关键表观遗传酶 (写字器,擦拭器,阅读器).
- 总结新兴的治疗目标和策略.
主要方法:
- 对心血管疾病中的表观遗传机制的文献综述.
- 对DNA甲基化 (DNMTs,TETs) 和基因素修饰 (HATs,HDACs) 的分析.
- 包括RNA甲基化 (m6A) 和它在病原发生中的作用.
主要成果:
- 特定的表观遗传酶,如DNMTs,HATs和HDACs是关键的调节者.
- 读者,如5-甲基细胞因子结合域蛋白,发挥作用.
- RNA甲基化 (m6A) 成为心血管疾病的重要因素.
- 经FDA批准的DNMTs和HDAC抑制剂显示出治疗潜力.
结论:
- 表观遗传修饰是心血管衰老和疾病的核心.
- 针对表观遗传酶提供了有前途的治疗途径.
- 新型的基因组修饰及其酶代表了新兴的目标.
更多相关视频
09:06Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
Published on: February 20, 2019
08:29A Cardiac Microphysiological System for Studying Ca2+ Propagation via Non-genetic Optical Stimulation
Published on: March 21, 2025
相关概念视频
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Epigenetic Regulation
X-chromosome...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Pathophysiology of Cardiac Performance
Cardiovascular Drugs: Classification based on Therapeutic Indications
Regulation of Angiogenesis and Blood Supply
